{"id":46868,"date":"2026-07-29T01:30:00","date_gmt":"2026-07-28T23:30:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=8a351c4057b0ae617a6dd0854b844025"},"modified":"2026-07-29T01:30:00","modified_gmt":"2026-07-28T23:30:00","slug":"travere-therapeutics-to-report-second-quarter-2026-financial-results","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=46868","title":{"rendered":"Travere Therapeutics to Report Second Quarter 2026 Financial Results"},"content":{"rendered":"<p>SAN DIEGO--(BUSINESS WIRE)--Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced it will report second quarter 2026 financial results on Tuesday, August 4, 2026, after the close of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business update at 4:30 p.m. ET.<\/p><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260728486314\/en\/2407040\/5\/Travere-Tx-Inline-fullcolor.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260728486314\/en\/2407040\/22\/Travere-Tx-Inline-fullcolor.jpg\" \/><\/a><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260728486314\/en\/2407040\/5\/Travere-Tx-Inline-fullcolor.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260728486314\/en\/2407040\/21\/Travere-Tx-Inline-fullcolor.jpg\" \/><\/a><p>\nThe webcast and dial-in information can be accessed on the Investor page of Travere\u2019s website at <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fir.travere.com%2Fevents-and-presentations&amp;esheet=54578576&amp;newsitemid=20260728486314&amp;lan=en-US&amp;anchor=https%3A%2F%2Fir.travere.com%2Fevents-and-presentations&amp;index=1&amp;md5=875523ba58ffc561d2ea493cb3591be7\" rel=\"nofollow\" shape=\"rect\">https:\/\/ir.travere.com\/events-and-presentations<\/a>. Following the live webcast, an archived version of the call will be available for 30 days on the Company\u2019s website.<\/p><p>\n<b>About Travere Therapeutics<\/b><\/p><p>\nAt Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent \u2013 that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope \u2013 today and tomorrow. For more information, visit <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftravere.com%2F&amp;esheet=54578576&amp;newsitemid=20260728486314&amp;lan=en-US&amp;anchor=travere.com&amp;index=2&amp;md5=0d1b2ca6f5bf39a1c27fe1cf4432c77e\" rel=\"nofollow\" shape=\"rect\">travere.com<\/a>.<\/p><br\/> <b>Contacts<\/b> <br\/><p>\nMedia:\n<br\/>888-969-7879\n<br\/><a  href=\"mailto:mediarelations@travere.com\" rel=\"nofollow\" shape=\"rect\">mediarelations@travere.com<\/a><br\/>\n<br\/>Investors:\n<br\/>888-969-7879\n<br\/><a  href=\"mailto:IR@travere.com\" rel=\"nofollow\" shape=\"rect\">IR@travere.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced it will report second quarter 2026 financial results on Tuesday, August 4, 2026, after the close of the U.S. financial markets. The Company will host a conference cal&#8230;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-46868","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/46868","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=46868"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/46868\/revisions"}],"predecessor-version":[{"id":46869,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/46868\/revisions\/46869"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=46868"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=46868"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=46868"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}